Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APO-IBUPROFEN-FC TABLET 200 MG - HSA Drug Approval Details

Approvals/HSA/APO-IBUPROFEN-FC TABLET 200 MG

Approved

THERAPEUTIC

APO-IBUPROFEN-FC TABLET 200 MG

APOTEX INC (CANADA)🇸🇬 Health Sciences Authority

Approval Date: Jun 3, 1991
Approval ID: 1458ab5e6171d59a
Company: APOTEX INC (CANADA)
Type: Therapeutic

Approval Details

Approval Id: 1458ab5e6171d59a
Drug Name: APO-IBUPROFEN-FC TABLET 200 MG
Product Name: APO-IBUPROFEN-FC TABLET 200 MG
Approval Number: SIN06016P
Approval Date: 1991-06-03
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: M01AE01
Atc Item Name: ibuprofen
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

IBUPROFEN

200 mg

IBUPROFEN

200 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 3, 1991

Approval ID

1458ab5e6171d59a

Type

Therapeutic

Back to HSA Approvals